Is INDV or LFCR more undervalued in 2026?

CirclFi compares Indivior Pharmaceuticals, Inc. (INDV) and Lifecore Biomedical, Inc. (LFCR) using 13 institutional-grade valuation models. INDV has a Quality of Company score of 5.9/10 while LFCR scores 4.9/10.

Which is a better buy — INDV or LFCR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INDV and LFCR valuations compare?

INDV at $36.61 and LFCR at $4.97 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INDV vs LFCR Valuation Comparison 2026 — Intrinsic Value Analysis

INDV

Drug Manufacturers - Specialty & Generic

Indivior Pharmaceuticals, Inc.

Quality

5.9

out of 10

Value Trap

SAFE

Price

$36.61

Last close

Models

12/13

Active

LFCR

Drug Manufacturers - Specialty & Generic

Lifecore Biomedical, Inc.

Quality

4.9

out of 10

Value Trap

SAFE

Price

$4.97

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	INDV Fair Value	INDV Upside	LFCR Fair Value	LFCR Upside
Bayesian DCF	Intrinsic	$8.36	-77.2%	—	—
Earnings Power Value	Intrinsic	$18.45	-49.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$24.81	-32.2%	$0.61	-86.0%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$42.30	+15.5%	$5.74	+15.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INDV vs LFCR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INDV vs LFCR — Which Stock Is More Undervalued?

INDV scores higher with a 5.9/10 quality rating vs LFCR's 4.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Indivior Pharmaceuticals, Inc. (INDV) and Lifecore Biomedical, Inc. (LFCR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INDV currently trades at $36.61 with a QOC of 5.9/10, while LFCR trades at $4.97 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).